Sales and markets
Bookmark
Audited by PwC
2010 was a very strong year from a sales perspective. High demand in the enzyme business resulted in double-digit organic sales growth for Novozymes.
Total sales in 2010 were DKK 9,724 million, an increase of 15% compared to 2009. Exchange rates impacted sales positively, and sales in local currency (LCY) increased by 10%. Organically, sales grew by 11% compared to 2009.
You can read more about our performance in Enzyme Business and BioBusiness by clicking on the menu to the left. You can also read about our sales in the different regions or learn more about the products that we have launched during 2010.
